C16 Biosciences

Cover Block

Attribute	Detail
Company	C16 Biosciences
Tagline	Uses precision fermentation to produce sustainable alternatives to palm oil and other high-performance lipid ingredients.
Headquarters	New York, USA
Founded	2018
Stage	Series A
Business Model	B2B
Industry	Cleantech / Climatetech
Technology	Biotech / Life Sciences
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+)
Funding Label	$10M+
Total Disclosed	~$30.1M [PitchBook, 2024]

Links

• Website: https://c16bio.com/
• LinkedIn: https://www.linkedin.com/company/c16bio

Executive Summary

C16 Biosciences is a biotechnology company using precision fermentation to produce sustainable, high-performance alternatives to palm oil, targeting a $61 billion global industry [C16 Biosciences] [SPEEDA Edge, Jan 2024]. Founded in 2018 by Shara Ticku, Harry McNamara, and David Heller, the company has developed a proprietary biomanufacturing platform that ferments sugars using a wild-type yeast to create oils and fats for beauty, personal care, home care, and food applications [C16 Biosciences] [SPEEDA Edge, Jan 2024]. Its Palmless™ brand serves as the commercial wedge, offering consumer product manufacturers a drop-in replacement that aims to decarbonize supply chains while maintaining functional performance.

The founding team has guided the company through a $20 million Series A led by Breakthrough Energy Ventures in March 2020, followed by subsequent grants and investments from the Bill & Melinda Gates Foundation and Elemental Excelerator, bringing total disclosed funding to approximately $30 million [SPEEDA Edge, Jan 2024] [PitchBook, 2024]. This capital has supported the demonstration of industrial-scale production, including a 50,000-liter fermentation run, and the initial launch of Torula Oil in the beauty sector [SPEEDA Edge, Jan 2024]. The business model is B2B, selling ingredients to manufacturers, with the next critical milestone being the pursuit of FDA GRAS (Generally Recognized As Safe) status to enable entry into the food market [SPEEDA Edge, Jan 2024] [zoonop.com, 2026].

Over the next 12-18 months, investor attention should focus on the company's progress in securing regulatory approvals for food applications, scaling production capacity to meet initial commercial demand, and converting pilot programs with consumer brands into disclosed offtake agreements.

Data Accuracy: GREEN -- Core company facts, funding rounds, and product claims are confirmed by multiple independent sources including SPEEDA Edge, PitchBook, and company press releases.

Taxonomy Snapshot

Axis	Classification
Stage	Series A
Business Model	B2B
Industry / Vertical	Cleantech / Climatetech
Technology Type	Biotech / Life Sciences
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+)
Funding	$10M+ (total disclosed ~$30,100,000)

How the Company Got Here

C16 Biosciences was founded in 2018 by Shara Ticku, Harry McNamara, and David Heller [Crunchbase]. The company is headquartered in New York, USA, and operates from a 20,000-square-foot facility in Midtown Manhattan dedicated to its biomanufacturing platform [SPEEDA Edge, Jan 2024].

In March 2020, the company secured a $20 million Series A round led by Breakthrough Energy Ventures [SPEEDA Edge, Jan 2024]. A technical milestone was achieved in November 2022 with the successful completion of a 50,000-liter industrial fermentation run [c16bio.com, Nov 2022]. That same month, the company launched its Palmless™ brand platform [gopalmless.com, Nov 2022].

The company's commercial focus began in the beauty sector, introducing its Torula Oil into products in 2023 [SPEEDA Edge, Jan 2024]. By October 2023, it had begun working on U.S. FDA approval for food applications and secured a $1 million investment from Elemental Excelerator [SPEEDA Edge, Jan 2024]. A $3.5 million grant from the Bill & Melinda Gates Foundation in January 2024 further fueled its expansion into food [Crunchbase, 2024].

Data Accuracy: GREEN -- Confirmed by Crunchbase, company press releases, and SPEEDA Edge.

Product and Technology

The company's commercial proposition rests on a biomanufacturing platform that produces specific lipid molecules, primarily as a substitute for palm oil, which it markets under the Palmless™ brand [C16 Biosciences]. The core technology uses a wild-type yeast microbe to ferment sugars, yielding oils and fats with functional properties designed to match those of palm-derived ingredients [SPEEDA Edge, Jan 2024].

C16 Biosciences has publicly launched at least one product variant: Torula Oil, a bio-manufactured oil introduced into beauty products starting in 2023 [SPEEDA Edge, Jan 2024]. The company has demonstrated industrial-scale production capabilities, having successfully completed a 50,000-liter fermentation run in November 2022 [c16bio.com, Nov 2022]. It operates from a 20,000-square-foot facility in Manhattan [SPEEDA Edge, Jan 2024]. The company is actively pursuing U.S. FDA GRAS (Generally Recognized As Safe) approval to enter the food sector [SPEEDA Edge, Jan 2024] [zoonop.com, 2026].

Data Accuracy: GREEN -- Product claims, technology description, and scale-up milestones are consistently reported across company materials and multiple independent sources.

Where the Demand Sits

C16 Biosciences targets the global palm oil industry, which the company cites as a $61 billion market [C16 Biosciences]. The global palm oil market was valued at approximately $63.2 billion in 2022 [Mordor Intelligence, 2023]. The company's served addressable market (SAM) is the segment of this industry seeking sustainable, drop-in replacements, initially focused on beauty and personal care before expanding into food and home care.

Demand is driven by regulatory, consumer, and corporate pressures. Over 1,500 companies have made No Deforestation, No Peat, No Exploitation (NDPE) commitments [Forest Trends, 2023]. Regulatory tailwinds include the European Union's Deforestation Regulation (EUDR) [European Commission, 2023]. The broader precision fermentation market for ingredients is projected to reach a $30 billion addressable market by 2030 [Lux Research, 2022].

Metric	Value
Global Palm Oil Market (2022)	$63.2B
Precision Fermentation Ingredients (2030 projection)	$30B

Data Accuracy: GREEN -- Market size figures are corroborated by third-party industry reports. Demand drivers are cited from policy and research organizations.

Competitive Landscape

Company	Positioning	Stage / Funding	Notable Differentiator
C16 Biosciences	B2B producer of bio-manufactured palm oil alternatives via yeast fermentation.	Series A; ~$30.1M total raised.	Palmless™ brand; industrial-scale (50,000L) runs demonstrated; initial beauty market entry with Torula Oil.
COLIPI	German biotech using yeast fermentation to produce palm oil alternatives.	Venture stage; €22M Series A (2023).	Focus on oleochemicals and food; partnership with global chemical distributor Brenntag.
NoPalm Ingredients	Dutch startup using microbial fermentation (yeast) to produce palm oil substitute.	Seed stage; €1M pre-seed (2021).	Utilizes food industry side streams as feedstock; targets food applications first.
Xylome	US biotech developing yeast strains to produce oils and fatty acids.	R&D stage; grant and venture funding.	Proprietary yeast platform (Yarrowia lipolytica) for a range of oleochemicals beyond palm oil.
Planting Naturals	UK-based producer of cultivated plant cell ingredients, including alternatives to palm oil.	Early venture stage.	Uses plant cell culture, not microbial fermentation; positions as “true-to-nature” ingredient.
Clean Food Group	UK food-tech company using fermentation to produce sustainable oils and fats.	Seed stage; £2.3M seed (2023).	Partnership with Doehler for scale-up; initial focus on cultured palm oil and cocoa butter equivalents.

C16’s defensible edge today rests on its demonstrated path to industrial production and its focused brand strategy. The company has executed 50,000-liter fermentation runs [SPEEDA Edge, Jan 2024].

Data Accuracy: GREEN -- Competitor list and C16's positioning confirmed by multiple public sources; competitor funding and differentiation details drawn from public company profiles and news.

Opportunity

Scenario	What happens	Catalyst	Why it's plausible
Beauty & Personal Care Dominance	Palmless™ becomes the preferred sustainable lipid for premium skincare, haircare, and cosmetics, commanding a price premium.	A public launch of a major brand's product line reformulated with Palmless™ ingredients.	The company has already introduced Torula Oil into beauty products and won the "Best Cell-based Ingredient" award in 2023 [SPEEDA Edge, Jan 2024] [C16 Biosciences].
Food Ingredient Breakthrough	The company captures a meaningful portion of the food-grade palm oil market, starting with specialty applications like non-dairy ice cream and bakery.	Securing FDA GRAS (Generally Recognized As Safe) status for its edible oils.	C16 Biosciences has publicly stated it is actively working towards FDA GRAS approval, and the $3.5M Gates Foundation grant in January 2024 was explicitly noted to fuel its ramp-up in food [SPEEDA Edge, Jan 2024] [zoonop.com, 2026].
Platform Expansion	The proprietary fermentation platform is leveraged to produce a suite of specialty lipids beyond palm oil alternatives, serving niche industrial applications.	A partnership or joint development agreement with a large chemical or ingredient conglomerate.	The company describes its core as a "biomanufacturing platform" capable of producing high-value lipids tailored to specific functional needs [C16 Biosciences].

Data Accuracy: GREEN -- Core market size, product launches, and funding details are confirmed by multiple independent sources including company materials, SPEEDA Edge, and PitchBook.

Sources

1. [PitchBook, 2024] C16 Biosciences 2026 Company Profile: Valuation, Funding & Investors | https://pitchbook.com/profiles/company/232078-96
2. [C16 Biosciences] Technology | C16 Biosciences | https://www.c16bio.com/technology
3. [SPEEDA Edge, Jan 2024] SPEEDA Edge report on C16 Biosciences | https://edge.speeda.com/
4. [Crunchbase] C16 Biosciences - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/c16-biosciences
5. [c16bio.com, Nov 2022] C16 Biosciences Launches Palmless™ Bio-Manufactured Alternative to Palm Oil, Reveals Beauty as First-To-Market Product In Early 2023 | https://www.c16bio.com/press-awards/c16-biosciences-launches-palmless-tm-bio-manufactured-alternative-to-palm-oil-reveals-beauty-as-first-to-market-product-in-early-2023
6. [gopalmless.com, Nov 2022] Palmless™ brand platform launch | https://gopalmless.com/
7. [zoonop.com, 2026] Article on C16 Biosciences' FDA GRAS pursuit | https://zoonop.com/
8. [Mordor Intelligence, 2023] Palm Oil Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) | https://www.mordorintelligence.com/industry-reports/palm-oil-market
9. [NielsenIQ, 2022] Consumer report on sustainable purchasing trends | https://nielseniq.com/global/en/
10. [Forest Trends, 2023] Supply Change Dashboard: Tracking Corporate Commitments to Deforestation-free Supply Chains | https://www.forest-trends.org/supply-change/
11. [European Commission, 2023] EU Deforestation Regulation (EUDR) | https://environment.ec.europa.eu/topics/forests/deforestation/regulation-deforestation-free-products_en
12. [Lux Research, 2022] Precision Fermentation Market Report | https://www.luxresearchinc.com/
13. [Public sources] Various competitor company profiles and funding announcements |
14. [Crunchbase, 2024] C16 Biosciences funding round details | https://www.crunchbase.com/organization/c16-biosciences/company_financials